A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Spanish brain-computer interface (BCI) company INBRAIN Neuroelectronics has announced its collaboration with Microsoft to explore AI applications for real-time brain-computer interface therapeutics.

Electrodes play a pivotal role in neural implants, including BCI. Electrodes are small pads and wires attached to the chest, ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

The chip that works this optical magic is not much to see. Under a powerful microscope attached to a computer at the Science ...

AI decodes brain activity and transforms thoughts into words, opening new frontiers for healthcare and assistive ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will accelerate commercialization of ...

The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...